Korea Food Research Institute is a global food R&D institution that contributes to the health of Korea.

Aptahem's development portfolio consists of aptamers , so-called synthetic (engineered) nucleic acid polymers. An aptamer consists of either single-stranded DNA or RNA (ssDNA or ssRNA). These molecules can bind specifically to already selected targets, including proteins and peptides with high affinity and specificity. Unlike antibodies, some aptamers exhibit stereoselectivity. Aptahem develops aptamer-based drugs for the treatment of life-threatening conditions where coagulation and inflammation interact in the disease process. Apta-1, the company's leading drug candidate, is an emergency medicine that is developed with the aim of stopping the organ and tissue damage that leads to the very high mortality rate for, among other things, sepsis patients.

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Instytut Chemii Bioorganicznej Pan (doing business as Institute of Bioorganic Chemistry) is a Polish company ultimately controlled by the Government of Poland. The firm operates as a physical-chemical biology and biotechnology center.

Konkuk University Industry-Academic Cooperation Foundation increases the competitiveness of industries by linking company and university.

NEC Soft provides information technology products and services that match the changes in the business environment and the level of customer growth. The company's business includes creating IT-driven management strategies, system development, implementation and operation, and outsourcing services. NEC Soft was established in 1975 and is based in Tokyo, Japan, with several office locations around Japan.

NanoSelect, Inc. develops and manufactures chemical and biological sensors to monitor the quality and safety of municipal water supply systems. It also offers carbon nanotube devices. The company was founded in 2003 and is headquarterd in Newark, DE

Consiglio Nazionale delle Ricerche is the largest public research facility in Italy. Founded in 1923, it has worked in the past as a government consultant on research and as a funding fund for university research grants. Since 1989 the CNR is a research institution, with the mission of carrying out research projects, promoting innovation and competitiveness of the national industrial system, the internationalization of the national research system, and providing technologies and solutions to emerging needs in the public and private sectors. . Objectives that are achieved through a wealth of human resources that has over 8000 employees, half of which is represented by researchers and technologists. About 4,000 young researchers are involved in post-doctoral research activities in the laboratories of the Institute, while an important contribution comes from collaborations, including international ones, with researchers from universities and companies, thus strengthening the national research system.

Forskarpatent i Syd AB specialises in the commercialisation, through licensing or new venture spinouts, of patentable inventions emanating mainly from Swedish universities. It holds a portfolio of projects in the format of shares in spinouts, partnered (licensed) and still unpartnered assets. It is involves in projects in pharmaceutical, technology, and food categories. The firm is categorized under patent agency operations. The company was founded on January 18, 1996 and is headquartered in Lund, Sweden.

Inscripta is developing the first benchtop platform for scalable digital genome engineering. The company’s advanced CRISPR-based platform, consisting of an instrument, consumables, software, and assays, offers a fully automated workflow that enables massively parallel, trackable editing of single cells at an unprecedented scale. Inscripta’s goal is to empower scientists whose gene editing research is stifled by current technical and licensing limitations. By providing this unique platform and engaging in collaborative business practices, such as making its MAD7 CRISPR nuclease-free for research and development purposes, the company enables scientists to realize a new era of biological discovery.

Part of CSL Ltd., CSL Behring GmbH is a German company located in Marburg. The firm manufactures plasma protein bio therapeutics for the treatment of rare and major diseases. Michael Schröder, Lutz Guenter Bonacker and Craig Shelanskey are the current co-CEOs of the firm.

The National Institute of Advanced Industrial Science and Technology (AIST), led by President Chubachi, is a public research institution funded by the Japanese government to a large extent. The present AIST is a rather new research organization established in 2001. However, AIST and its predecessor organizations have been contributing to society through continuous advancement in technologies and support to Japanese industries since 1882. Headquarters of AIST are located in Tsukuba and Tokyo. AIST has over 40 autonomous research units in various innovative research fields, and the units are located at ten research bases and several sites (smaller than research bases) of AIST all over Japan. About 2300 researchers (about 2000 with tenure: about 80 from abroad) and a few thousands of visiting scientists, post-doctoral fellows, and students from home and abroad are working at AIST. About 650 permanent administrative personnel and many temporary staff support research works of AIST.

Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France.

Biois is a private company headquartered in Guro-gu, the South Korea, that provides diagnostics services. It was founded in 2000.

Xi'an Rongqingchang Biotechnology Co., Ltd., established on 2017-10-18, Business scope includes technical development of biotechnology products,technical consulting,technology transfer;Research and development of biomedicine and medical devices,technical consulting;Processing of agricultural products,Sales;pesticide,Biological reagents and chemical reagents(non-hazardous,monitor,precursor chemicals)production,Sales;Import and export of goods and technology(country restrictions,Excluding goods and technologies that are prohibited and subject to approval for import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Conceptual MindWorks, Inc. provides research and technical support services to the military and healthcare industry. It also offers scientific and engineering research services. The company was founded by Elaine Mendoza on July 5, 1990 and is headquartered in San Antonio, TX.